Concepedia

François Santinon

FS

4

Publications

131

Citations

4

H-Index

2016

Active since

Affiliations

Sorbonne Paris Cité(Current)

Hôpital Maisonneuve-Rosemont

Université Sorbonne Paris Nord

Université de Montréal

Inserm

François Santinon is an author at Sorbonne Paris Cité specializing in oncology, tumor immunity, and cancer research.

Top concepts

Publications per year

2016–2022

4

Publications

4

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

Jérôme Biton, Allan Thiolat, François Santinon et al. · The Journal of Immunology · 2016 · 55 citations · Full text

Involvement of Tumor Necrosis Factor Receptor Type II in <i>FoxP3</i> Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

François Santinon, Maxime Batignes, Majda Lyna Mebrek et al. · Arthritis & Rheumatology · 2019 · 37 citations

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy

Janna Krueger, François Santinon, Alexandra Kazanova et al. · PLoS ONE · 2021 · 20 citations · Full text

, , +15

Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade

François Santinon, Bennani Fatima Ezzahra, Meriem Bachais et al. · Scientific Reports · 2022 · 19 citations · Full text

Rows per page

1–4 of 4